High prevalence of frailty in patients with adrenal adenomas and adrenocortical hormone excess: a cross-sectional multi-centre study with prospective enrolment
Prerna Dogra(Mayo Clinic in Arizona), Irina Bancos(Mayo Clinic in Arizona), Sumitabh Singh(Mayo Clinic in Florida), Elizabeth J. Atkinson(Mayo Clinic in Arizona), Dimitra Baikousi(Evangelismos Hospital), Adina F. Turcu(University of Michigan), Rohit Nathani(Southwestern Medical Center), Karthik Thangamuthu(Mayo Clinic in Arizona), Danae A. Delivanis(IS practice), Shobana Athimulam(Henry Ford Health System), Sara J. Achenbach(Mayo Clinic in Florida), Natalia Genere(Washington University in St. Louis), Urszula Ambroziak(Medical University of Warsaw), Darko Kaštelan(University Hospital Centre Zagreb), Lana Šambula, Catherine D Zhang(Medical College of Wisconsin), Jasmine Saini(Yale New Haven Hospital), Zara Salman(University of Michigan), Raul Gregg Garcia(Mayo Clinic in Arizona), Nathan K. LeBrasseur(WinnMed)
Cited by 33
Related Papers
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
|European Journal of Endocrinology|2016|1.5k
Cellular senescence mediates fibrotic pulmonary disease
|Nature Communications|2017|1.5k
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
|EBioMedicine|2019|1.2k
New loci associated with kidney function and chronic kidney disease
|Nature Genetics|2010|809